<p>We included tumors from newly diagnosed or untreated follicular lymphoma in this study. Samples consented to the <a href="https://trp.cancer.gov/spores/abstracts/uiowa_lymphoma.htm">University of Iowa and Mayo Clinic Lymphoma Specialized Program of Research Excellence (SPORE)</a> were included for data sharing. RNA was extracted from 1) CD19 sorted B cells from tumor cell suspension frozen in dimethyl sulfoxide (DMSO; RNA Tumor B Cell, n=77), 2) tumor cell suspensions frozen in DMSO (RNA Tumor DMSO, n=78), and 3) tumor tissue sections frozen in optimal cutting temperature compound (OCT; RNA Tumor OCT, n=53). For RNA sequencing, library preparation was done using the Illumina TruSeq RNA Exome Kit and sequenced with 100 nucleotide paired-end reads using the HiSeq 4000. DNA was extracted from 1) tumor cell suspensions frozen in DMSO (DNA Tumor DMSO, n=78), 2) tumor tissue sections frozen in OCT (DNA Tumor OCT, n=33), and 3) germline DNA from peripheral blood (n=102) and from normal tissue adjacent tumor (n=9). For whole exome sequencing (WES), library preparation was done using the Agilent SureSelect XT kit and sequenced with 100 nucleotide paired-end reads using the Illumina HiSeq 4000. </p>

Genomic Analysis of Follicular Lymphoma

18 variables across Demographics, Disease Events

Genomic Analysis of Follicular Lymphoma

Demographics (2)

Disease Events (1)

Other (15)